Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 5/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.42 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.42 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.42 |
| ▸ | FAAH | O00519 | 7/20 | 0.41 |
| ▸ | CES1 | P23141 | 5/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27860089 | 0.98 | S1PR2 (0.40) | S1PR2S1PR1S1PR3S1PR4FAAH | |
| SCHEMBL27742916 | 0.86 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4FAAH | |
| SCHEMBL23850596 | 0.86 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4FAAH | |
| SCHEMBL28627217 | 0.86 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4FAAH | |
| SCHEMBL29191930 | 0.84 | S1PR2 (0.42) | S1PR2S1PR1S1PR3S1PR4FAAH | |
| SCHEMBL28958760 | 0.81 | CA2 (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28092086 | 0.81 | CA2 (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL22160006 | 0.79 | CA2 (0.47) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL3365888 | 0.79 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL28718189 | 0.79 | CA1 (0.40) | S1PR2S1PR1S1PR3S1PR4FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113302196-B | EGFR inhibitor, composition and application thereof | 贝达药业股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-113302196-A | EGFR inhibitor and composition and application thereof | 贝达药业股份有限公司 | 2021-08-24 | — | — | CN | disclosed |
| WO-2020147702-A1 | EGFR INHIBITORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2020-07-23 | — | — | WO | disclosed |